Mavik and metastases to central nervous system Patient Reports February 11, 2012
Mavik Side Effects Report #5375501-2
Mavik side effect was reported by a Physician from CANADA on June 21, 2007. Male patient, weighting 158.7 lb, was diagnosed with hypertension and was treated with Mavik. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, metastases to central nervous system. Mavik dosage: unknown. During the same period patient was treated with CELECOXIB. Patient recovered.
Mavik Side Effects Report #4560150-6
Mavik side effect was reported by a Consumer or non-health professional from on Jan 14, 2005. Male patient, weighting 152.1 lb, was diagnosed with hypertension and was treated with Mavik. After drug was administered, patient experienced the following side effects: metastases to abdominal cavity, metastases to central nervous system, metastases to chest wall, non-small cell lung cancer, pleural effusion. Mavik dosage: unknown. During the same period patient was treated with COMBIVENT. Patient recovered.
Mavik Side Effects Report #4584526-6
Mavik side effect was reported by a Consumer or non-health professional from on Jan 14, 2005. Male patient, weighting 152.1 lb, was diagnosed with hypertension and was treated with Mavik. After drug was administered, patient experienced the following side effects: metastases to abdominal cavity, metastases to central nervous system, metastases to chest wall, non-small cell lung cancer, pleural effusion. Mavik dosage: unknown. During the same period patient was treated with COMBIVENT. Patient recovered.
Mavik Side Effects Report #4606273-4
Mavik side effect was reported by a Consumer or non-health professional from on Jan 14, 2005. Male patient, weighting 152.1 lb, was diagnosed with hypertension and was treated with Mavik. After drug was administered, patient experienced the following side effects: metastases to abdominal cavity, metastases to central nervous system, metastases to chest wall, non-small cell lung cancer, pleural effusion. Mavik dosage: unknown. During the same period patient was treated with COMBIVENT. Patient recovered.
Mavik and metastases to central nervous system 